STE
STERIS Plc (Ireland)
NYSE · Healthcare · Medical - Devices · IE
$247.91
+7.16%Nov 4, 2026, 23:51 UTC
STERIS plc reported quarterly earnings of $2.94 per share, up from $2.47 per share a year earlier.
Source:Nov 4, 2026, 21:30 UTC
STERIS plc reported fiscal 2027 second-quarter revenue of $1.6 billion, up 9% year over year, with constant-currency organic revenue growth of 8%.
Source:Oct 28, 2026, 20:30 UTC
STERIS plc announced a quarterly dividend of $0.69 per share, payable on December 17, 2026, to shareholders of record on November 17, 2026.
Source:Oct 13, 2026, 20:35 UTC
STERIS and Purchaser entered into a commitment for up to $2.0 billion in aggregate senior unsecured bridge financing from JPMorgan Chase Bank, N.A. and Goldman Sachs Bank USA.
Oct 13, 2026, 20:35 UTC
STERIS plc, through its wholly owned subsidiary STERIS plc, agreed to acquire all equity interests in STERIS plc for $2.1 billion in cash, with potential earnout consideration of up to $150 million.
Oct 12, 2026, 12:08 UTC
STERIS plc announced that it will buy Xodus Medical, Inc. for $2.1 billion.
Aug 9, 2026, 08:04 UTC
STERIS announced a $600 million investment to build a new chemistry manufacturing, research and distribution complex in North Carolina.
Source:Aug 5, 2026, 20:30 UTC
STERIS plc announced its financial results for the fiscal 2027 first quarter ended June 30, 2026, reporting total revenue of $1.5 billion, a 7% increase from $1.4 billion in the prior-year quarter, with constant currency organic revenue growth of 6%.
Aug 5, 2026, 12:45 UTC
STERIS announced a $600 million investment to build a Formulated Chemistries manufacturing and distribution Center of Excellence in North Carolina, supporting sterilization and disinfection for global healthcare and pharmaceutical industries.
Jul 30, 2026, 20:30 UTC
STERIS plc announced a quarterly interim dividend of $0.69 per share, a $0.06 increase, marking its 21st consecutive year of dividend growth.
Source: